$ARNA, $GE, $MRVL, $MNST, $NKTR, $PG
Daily HeffX-LTN reviews dozens of the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is a list of The Street’s Key analysts outlook for Key issues for Friday as follows:
Arena Pharmaceutical Inc. (NASDAQ:ARNA) was started with Buy rating at Berenberg with a 55 price target, and that compares with a Wall Street consensus target at 62.78.
General Electric Co. (NYSE:GE) was raised to Neutral from Underweight at JPMorgan with a 6 price target. The venerable industrial has been pounded this year, and the change is a boost for the company as the analyst has been a long-time Bear on the shares. The stock has traded between $6.66 and 19.39 over the past year. The consensus price target is 12.83.
Marvell Ltd. (NASDAQ: MRVL) was raised to Buy from Neutral at Citigroup. The 52-wk trading range for the stock is 14.69 – 25.18, and the consensus price target is 23.72.
Monster Beverage Corp. (NASDAQ:MNST) was started with a Sell rating at UBS, which has a 48 price target. That figure compares with a consensus price target of 62.71.
Nektar Therapeutics Inc. (NASDAQ:NKTR) was started with a Buy rating at Goldman Sachs, which has a price target of 62. That is in comparison to a massive consensus target of 81.
Procter & Gamble Co. (NYSE:PG) was raised to Buy from Neutral at Merrill Lynch. The 52-wk trading range for the consumer goods giant is 70.73 – 94.86. The consensus price target is at 89.47. The shares closed Thursday at 96.49.
Have a terrific weekend.
Latest posts by Paul Ebeling (see all)
- Buy a New Ferrari to Drive, Buy the Stock as an Investment - December 9, 2019
- China Spared New 15 December Trump Tariffs - December 9, 2019
- President Trump Leads All Dems in Battleground States - December 9, 2019